About Laurus Bio
Laurus Bio is a company based in Bengaluru (India) founded in 2005 by Rajesh Krishnamurthy was acquired by Laurus Labs in September 2023. Laurus Bio has raised $18.89 million across 1 funding round from investors including Laurus Labs, Eight Roads Ventures and F-Prime Capital. The company has 347 employees as of April 03, 2024. Laurus Bio offers products and services including Animal-Free Recombinant Proteins and Microbial Precision Fermentation CDMO. Laurus Bio operates in a competitive market with competitors including KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others.
- Headquarter Bengaluru, India
- Employees 347 as on 03 Apr, 2024
- Founders Rajesh Krishnamurthy
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Laurus Bio Private Limited
- Date of Incorporation 14 Jul, 2005
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$3.56 M (USD)-4.42as on Mar 31, 2017
-
Net Profit
-$902.1 K (USD)-8.21as on Mar 31, 2017
-
EBITDA
-$388.42 K (USD)-6.32as on Mar 31, 2017
-
Total Equity Funding
$18.89 M (USD)
in 1 rounds
-
Latest Funding Round
$18.89 M (USD), Series B
Dec 06, 2024
-
Investors
Laurus Labs
& 2 more
-
Employee Count
347
as on Apr 03, 2024
-
Acquired by
Laurus Labs
(Sep 11, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Laurus Bio
Laurus Bio offers a comprehensive portfolio of products and services, including Animal-Free Recombinant Proteins and Microbial Precision Fermentation CDMO.
Proteins and growth factors for safe medicines and sustainable food applications.
Services for strain engineering and fermentation scale-up in biopharma.
People of Laurus Bio
Unlock access to complete
Unlock access to complete
Funding Insights of Laurus Bio
Laurus Bio has successfully raised a total of $18.89M through 1 strategic funding round. The most recent funding activity was a Series B round of $18.89 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Laurus Bio
Laurus Bio has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Laurus Labs, Eight Roads Ventures and F-Prime Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investment and global platform support for startups.
|
Locked | Locked | Locked | |
|
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
|
Locked | Locked | Locked | |
|
Pharmaceutical and biotechnology company
|
Locked | Locked | Locked |
Investor details for Laurus Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Laurus Bio
Investment portfolio details for Laurus Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Laurus Bio
Detailed financials for Laurus Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Laurus Bio Comparisons
Peer comparison for Laurus Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Laurus Bio
Laurus Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of protein formulation, process & cell line development, and cGMP services
|
|
| Locked | Locked | Locked |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| Locked | Locked | Locked |
Integrated biologics development and manufacturing are provided as a CDMO.
|
|
| Locked | Locked | Locked |
Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec.
|
|
| Locked | Locked | Locked |
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
|
Detailed competitors of Laurus Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Laurus Bio
Complete news archive for Laurus Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Laurus Bio
Laurus Bio was founded in 2005 and raised its 1st funding round 19 years after it was founded.
Laurus Bio is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Rajesh Krishnamurthy is the current CEO of Laurus Bio. They have also founded this company.
Laurus Bio is a funded company, having raised a total of $18.89M across 1 funding round to date.
As of Apr 03, 2024, the latest employee count at Laurus Bio is 347.
Annual revenue of Laurus Bio is $3.56M as on Mar 31, 2017.
Laurus Bio was founded in 2005 in Bengaluru, India, as an integrated biomanufacturing organization. Precision fermentation is utilized to engineer microbes for producing animal-free proteins and growth factors. Services extend to the biopharma, food, and regenerative medicine sectors, including clone development, strain engineering, and large-scale manufacturing under cGMP standards. Operations support cultured meat, cell culture media, and vaccine production across various markets.
Laurus Bio's top competitors include KBI Biopharma, Aldevron and Ovagen.
Laurus Bio offers Animal-Free Recombinant Proteins and Microbial Precision Fermentation CDMO.
Laurus Bio has 3 investors. Key investors include Laurus Labs, Eight Roads Ventures, and F-Prime Capital.